Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I McFarlane

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Vascular Health and Risk Management|December 6, 2011
Telmisartan and cardioprotectionPhilippe R Akhrass, Samy I McFarlane
Advances in Geriatric Medicine and Research|August 9, 2021
Obesity, Vascular Disease and Frailty in Aging Women with HIVDeborah R Gustafson, Samy I McFarlane
Evidence-Based Cardiovascular Medicine|December 29, 2005
Calcium channel blockers reduce risk of stroke in people with hypertension. CommentaryJames R Sowers, Samy I McFarlane
Journal of Clinical Hypertension (Greenwich, Conn.)|July 15, 2005
Gender disparities in the control of cardiovascular risk factors in people with diabetesSamy I McFarlane, James R Sowers
Current Diabetes Reports|February 5, 2009
Inhibition of the RAS and prevention of diabetes and CVD: mechanistic insights and lessons learned from clinical trialsSamy I McFarlane, Jeffrey S Borer
Nutrition & Metabolism|July 16, 2005
The case for low carbohydrate diets in diabetes managementSurender K Arora, Samy I McFarlane
Cureus|July 27, 2022
Arteria Lusoria With Right-Sided Aortic Arch and Atrial Septal Defect Associated With Extensive Thrombosis and Paradoxical Embolism: A Case ReportTanuj Gupta, Nader Jamaleddine, Samy I McFarlane
Glycoconjugate Journal|January 2, 2001
Lectin analysis of human immunoglobulin G N-glycan sialylationM Dalziel, I McFarlane, J S Axford
Current Hypertension Reports|May 26, 2005
Clinical trials report. Hypertensive diabetic patients: INVESTing in the prevention of cardiovascular diseaseSurender Arora, John Nicasio, Samy I McFarlane
Cardiovascular Drug Reviews|July 9, 2003
Calcium antagonists in patients with type 2 diabetes and hypertensionSamy I McFarlane, Amal Farag, James Sowers
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Vascular Health and Risk Management|December 6, 2011
Telmisartan and cardioprotectionPhilippe R Akhrass, Samy I McFarlane
Advances in Geriatric Medicine and Research|August 9, 2021
Obesity, Vascular Disease and Frailty in Aging Women with HIVDeborah R Gustafson, Samy I McFarlane
Evidence-Based Cardiovascular Medicine|December 29, 2005
Calcium channel blockers reduce risk of stroke in people with hypertension. CommentaryJames R Sowers, Samy I McFarlane
Journal of Clinical Hypertension (Greenwich, Conn.)|July 15, 2005
Gender disparities in the control of cardiovascular risk factors in people with diabetesSamy I McFarlane, James R Sowers
Current Diabetes Reports|February 5, 2009
Inhibition of the RAS and prevention of diabetes and CVD: mechanistic insights and lessons learned from clinical trialsSamy I McFarlane, Jeffrey S Borer
Nutrition & Metabolism|July 16, 2005
The case for low carbohydrate diets in diabetes managementSurender K Arora, Samy I McFarlane
Cureus|July 27, 2022
Arteria Lusoria With Right-Sided Aortic Arch and Atrial Septal Defect Associated With Extensive Thrombosis and Paradoxical Embolism: A Case ReportTanuj Gupta, Nader Jamaleddine, Samy I McFarlane
Glycoconjugate Journal|January 2, 2001
Lectin analysis of human immunoglobulin G N-glycan sialylationM Dalziel, I McFarlane, J S Axford
Current Hypertension Reports|May 26, 2005
Clinical trials report. Hypertensive diabetic patients: INVESTing in the prevention of cardiovascular diseaseSurender Arora, John Nicasio, Samy I McFarlane
Cardiovascular Drug Reviews|July 9, 2003
Calcium antagonists in patients with type 2 diabetes and hypertensionSamy I McFarlane, Amal Farag, James Sowers
Pageof 24